Edition:
United States

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

1.86USD
16 Oct 2018
Change (% chg)

$0.10 (+5.68%)
Prev Close
$1.76
Open
$1.76
Day's High
$1.99
Day's Low
$1.72
Volume
113,641
Avg. Vol
38,521
52-wk High
$4.56
52-wk Low
$1.65

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.09 -0.041
Mar '18 0.15 -0.047
FY 2017 Dec '17 0.11 -0.060
Sep '17 0.03 -0.086
Jun '17 0.01 -0.052
Mar '17 0.08 -0.057
FY 2016 Dec '16 0.04 -0.059
Sep '16 0.05 -0.067
Jun '16 0.15 -0.084
Mar '16 0.04 -0.076
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 86.20 32.69
P/E High - Last 5 Yrs. -- 290.01 45.21
P/E Low - Last 5 Yrs. -- 90.56 23.82
Beta 0.85 0.93 0.88
Price to Sales (TTM) 1,110.25 123.88 5.82
Price to Book (MRQ) -- 15.34 4.90
Price to Tangible Book (MRQ) -- 14.54 6.53
Price to Cash Flow (TTM) -- 70.75 22.98
% Owned Institutions 5.90 13.94 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.34 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.56 5.38
Payout Ratio(TTM) -- 16.91 43.96

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -93.70 391.55 7.73
Sales (TTM) vs TTM 1 Yr. Ago -42.39 73.89 5.32
Sales - 5 Yr. Growth Rate -38.07 30.83 9.89
EPS (MRQ) vs Qtr. 1 Yr. Ago 37.65 24.83 22.57
EPS (TTM) vs TTM 1 Yr. Ago 55.50 -- --
EPS - 5 Yr. Growth Rate -- 37.95 10.95
Capital Spending - 5 Yr. Growth Rate -39.54 38.70 14.94

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.94 1.94 2.25
Current Ratio (MRQ) 0.94 5.32 3.05
LT Debt to Equity (MRQ) -- 35.04 12.63
Total Debt to Equity (MRQ) -- 36.85 16.96
Interest Coverage (TTM) -88.90 -97.99 37.54

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 15.24 40.03 54.92
Gross Margin - 5 Yr. Avg. 89.96 49.23 52.45
EBITD Margin (TTM) -6,209.52 -- --
EBITD - 5 Yr. Avg -383.86 -574.53 11.10
Operating Margin (TTM) -6,210.97 -770.03 4.36
Operating Margin - 5 Yr. Avg. -384.15 -594.78 6.45
Pre-Tax Margin (TTM) -6,370.48 -731.81 5.41
Pre-Tax Margin - 5 Yr. Avg. -387.78 -600.11 6.89
Net Profit Margin (TTM) -6,370.48 -732.73 1.68
Net Profit Margin - 5 Yr. Avg. -387.36 -603.07 3.14
Effective Tax Rate (TTM) -- 23.70 23.23
Effective Tax Rate - 5 Yr. Avg. -- 18.84 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) 45,045 22,887,281 812,879,200
Net Income/Employee (TTM) -2,869,585 1,727,321 95,609,515
Receivable Turnover (TTM) 12.23 19.88 5.78
Inventory Turnover (TTM) 8.87 2.39 3.60
Asset Turnover (TTM) 0.21 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -1,329.05 -0.96 10.94
Return on Assets - 5 Yr. Avg. -530.60 3.30 12.05
Return on Investment (TTM) -- 0.73 14.32
Return on Investment - 5 Yr. Avg. -- 2.37 15.66
Return on Equity (TTM) -- 1.82 16.04
Return on Equity - 5 Yr. Avg. -- 3.23 16.92
  1 Year 3 Year 5 Year
Sales % -89.73 -56.13 -38.07
EPS (TTM) % 40.63 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nymox Pharmaceutical Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.25%
# of Holders: 78
Total Shares Held: 4,136,629
3 Mo. Net Change: -85,591
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 7
# Reduced Positions: 1
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.